This article is more than 5 years old. Information may no longer be current.

Abbott reports $5.2 billion in third-quarter worldwide sales

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Abbott reported $5.2 billion in worldwide sales in the third quarter, a 10.9% increase on an operational basis and a 1.4% increase on a reported basis from the previous year, according to a press release.

Net earnings increased 7.6% from the same quarter a year ago, from $538 million to $580 million. Diluted earnings per common share increased 5.6%, from $0.36 to $0.38.

Medical Optics worldwide sales were $283 million, an increase of 3% on an operational basis and a decrease of 5.3% on a reported basis in the third quarter, which included an unfavorable 8.3% effect of foreign exchange. Cataract product sales represented 70% of Medical Optics sales, with an increase in the high single digits.